Abacavir/Lamivudine placebo

DRUG2 trials

Sponsors

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections, ViiV Healthcare

Conditions

HIV InfectionsInfection, Human Immunodeficiency Virus I

Phase 3

Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults

CompletedNCT00118898

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsHIV Infections

Start: 2005-09-30End: 2009-11-30Updated: 2018-10-12

A Trial Comparing GSK1349572 50mg Plus Abacavir/Lamivudine Once Daily to Atripla (Also Called The SINGLE Trial)

CompletedNCT01263015

ViiV HealthcareInfection, Human Immunodeficiency Virus I

Start: 2011-02-01End: 2015-12-03Updated: 2018-04-04

Related Papers

Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202

Antimicrobial Agents and Chemotherapy2019-01-1416 citations

Safety and Efficacy of DTG Plus ABC/3TC for Treatment-Naive Patients with HIV

MD Conference Express2014-11-01

Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.

2014-07-01147 citations

Outcomes by sex following treatment initiation with atazanavir plus ritonavir or efavirenz with abacavir/lamivudine or tenofovir/emtricitabine.

2013-11-1825 citations

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

New England Journal of Medicine2013-11-06862 citations

Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.

2012-11-2950 citations

HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.

2012-11-1218 citations

Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.

2011-07-0199 citations

Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTG A5202.

2011-06-01367 citations

Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

2011-02-14241 citations

Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

2009-12-01224 citations